{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:10:51Z","timestamp":1776309051467,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","award":["74652"],"award-info":[{"award-number":["74652"]}],"id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is limited research to guide TB treatment specifically in pregnant women and few studies have described the presentation of TB in pregnant women. We aimed to understand TB presentation and treatment outcomes in pregnant women in a low HIV burden setting. We describe a cohort of women of childbearing age treated for TB disease in Lima, Peru, and compare clinical presentation and treatment outcomes among pregnant and non-pregnant women between 2009 and 2012, including 36 pregnant women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a prospective cohort study. Subjects were recruited from across 106 public health centers in Lima, Peru. Baseline demographic, medical history, and drug-susceptibility test results were collected. We used descriptive statistics to describe demographic and clinical characteristics of the women using Pearson chi-squared, Fisher\u2019s exact tests, or Kruskal-Wallis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 4500 individuals with pulmonary TB disease, 1334 women were included in analysis with 36 (2.69%) pregnant women. Pregnant women had similar demographics, past medical histories, and clinical presentation to non-pregnant women, except being more likely to be married (<jats:italic>p<\/jats:italic>\u2009=\u20090.01) and have cardiac disease (<jats:italic>p<\/jats:italic>\u2009=\u20090.04) and less likely to have weight loss (<jats:italic>p<\/jats:italic>\u2009=\u20090.05). Twenty (71.4%) pregnant women had pan-susceptible TB compared with 616 (63.1%) non-pregnant women; four (14.3%) pregnant women had mono-resistant TB compared with 154 (15.8%) non-pregnant women; and four (14.3%) pregnant women had multi-drug-resistant TB compared with 140 (14.3%) of non-pregnant women (<jats:italic>p<\/jats:italic>\u2009=\u20090.53). Twenty-eight (96.6%) pregnant women had a successful outcome (cure, completed treatment, treatment ended early by clinical team) while one (3.4%) had an unsuccessful outcome (treatment failed) and 1074 (97.3%) non-pregnant women had a successful outcome while 30 (2.7%) had an unsuccessful outcome (<jats:italic>p<\/jats:italic>\u2009=\u20090.56).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this cohort with low HIV co-infection, we found high TB treatment success rates in both pregnant and non-pregnant women, irrespective of drug-susceptibility profiles. If treated appropriately, pregnant women with TB disease can have successful outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-05416-6","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T13:03:48Z","timestamp":1600434228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Tuberculosis clinical presentation and treatment outcomes in pregnancy: a prospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0476-6295","authenticated-orcid":false,"given":"Brittney J.","family":"van de Water","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith B.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-Chin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Trevisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Lecca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Galea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Calderon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Yataco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes C.","family":"Becerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"5416_CR1","first-page":"2","volume-title":"TB and Gender","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. TB and Gender. Geneva: WHO; 2018. p. 2."},{"issue":"6","key":"5416_CR2","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323\u201333.","journal-title":"Lancet Glob Health"},{"issue":"12","key":"5416_CR3","doi-asserted-by":"publisher","first-page":"e710","DOI":"10.1016\/S2214-109X(14)70330-4","volume":"2","author":"J Sugarman","year":"2014","unstructured":"Sugarman J, Colvin C, Moran AC, Oxlade O. Tuberculosis in pregnancy: an estimate of the global burden of disease. Lancet Glob Health. 2014;2(12):e710\u20136.","journal-title":"Lancet Glob Health"},{"issue":"Suppl 2","key":"5416_CR4","doi-asserted-by":"publisher","first-page":"S216","DOI":"10.1093\/infdis\/jis009","volume":"205","author":"H Getahun","year":"2012","unstructured":"Getahun H, Sculier D, Sismanidis C, Grzemska M, Raviglione M. Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J Infect Dis. 2012;205(Suppl 2):S216\u201327.","journal-title":"J Infect Dis"},{"issue":"3","key":"5416_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1053\/siny.2000.0022","volume":"5","author":"P Thillagavathie","year":"2000","unstructured":"Thillagavathie P. Current issues in maternal and perinatal tuberculosis: impact of the HIV-1 epidemic. Semin Neonatol. 2000;5(3):189\u201396.","journal-title":"Semin Neonatol"},{"issue":"11","key":"5416_CR6","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/cid\/cis732","volume":"55","author":"JS Mathad","year":"2012","unstructured":"Mathad JS, Gupta A. Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clin Infect Dis. 2012;55(11):1532\u201349.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5416_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/1471-0528.14408","volume":"124","author":"S Sobhy","year":"2017","unstructured":"Sobhy S, Babiker Z, Zamora J, Khan KS, Kunst H. Maternal and perinatal mortality and morbidity associated with tuberculosis during pregnancy and the postpartum period: a systematic review and meta-analysis. BJOG. 2017;124(5):727\u201333.","journal-title":"BJOG."},{"key":"5416_CR8","volume-title":"Tuberculosis: WHO global tuberculosis report 2014","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Tuberculosis: WHO global tuberculosis report 2014. Geneva: WHO; 2014."},{"issue":"6","key":"5416_CR9","first-page":"564","volume":"5","author":"AE Czeizel","year":"2001","unstructured":"Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. A population-based case-control study of the safety of oral anti-tuberculosis drug treatment during pregnancy. Int J Tuberc Lung Dis. 2001;5(6):564\u20138.","journal-title":"Int J Tuberc Lung Dis."},{"issue":"5","key":"5416_CR10","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.21037\/jtd.2018.05.11","volume":"10","author":"A Esmail","year":"2018","unstructured":"Esmail A, Sabur NF, Okpechi I, Dheda K. Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill. J Thorac Dis. 2018;10(5):3102\u201318.","journal-title":"J Thorac Dis"},{"key":"5416_CR11","doi-asserted-by":"publisher","first-page":"l5894","DOI":"10.1136\/bmj.l5894","volume":"367","author":"MC Becerra","year":"2019","unstructured":"Becerra MC, Huang C-C, Lecca L, et al. Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study. BMJ. 2019;367:l5894.","journal-title":"BMJ."},{"key":"5416_CR12","volume-title":"Definitions and reporting framework for tuberculosis","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Definitions and reporting framework for tuberculosis. Geneva: World Health Organization; 2013."},{"issue":"2","key":"5416_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5588\/pha.12.0092","volume":"3","author":"JT Galea","year":"2013","unstructured":"Galea JT, Contreras C, Lecca L, et al. Rapid home-based HIV testing to reduce costs in a large tuberculosis cohort study. Public Health Action. 2013;3(2):172\u20134.","journal-title":"Public Health Action"},{"issue":"6","key":"5416_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/cid\/cix851","volume":"66","author":"N Salazar-Austin","year":"2018","unstructured":"Salazar-Austin N, Hoffmann J, Cohn S, et al. Poor obstetric and infant outcomes in human immunodeficiency virus-infected pregnant women with tuberculosis in South Africa: the Tshepiso study. Clin Infect Dis. 2018;66(6):921\u20139.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5416_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.siny.2009.02.001","volume":"14","author":"M Adhikari","year":"2009","unstructured":"Adhikari M. Tuberculosis and tuberculosis\/HIV co-infection in pregnancy. Semin Fetal Neonatal Med. 2009;14(4):234\u201340.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"11","key":"5416_CR16","doi-asserted-by":"publisher","first-page":"e0164249","DOI":"10.1371\/journal.pone.0164249","volume":"11","author":"A Bekker","year":"2016","unstructured":"Bekker A, Schaaf HS, Draper HR, Kriel M, Hesseling AC. Tuberculosis disease during pregnancy and treatment outcomes in HIV-infected and uninfected women at a referral hospital in Cape Town. PLoS One. 2016;11(11):e0164249.","journal-title":"PLoS One"},{"key":"5416_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/s12879-014-0617-x","volume":"14","author":"HT Nguyen","year":"2014","unstructured":"Nguyen HT, Pandolfini C, Chiodini P, Bonati M. Tuberculosis care for pregnant women: a systematic review. BMC Infect Dis. 2014;14:617.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"5416_CR18","first-page":"706","volume":"11","author":"M Khan","year":"2007","unstructured":"Khan M, Pillay T, Moodley J, Ramjee A, Padayatchi N. Pregnancies complicated by multidrug-resistant tuberculosis and HIV co-infection in Durban, South Africa. Int J Tuberc Lung Dis. 2007;11(6):706\u20138.","journal-title":"Int J Tuberc Lung Dis."},{"issue":"10","key":"5416_CR19","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1086\/598191","volume":"48","author":"E Palacios","year":"2009","unstructured":"Palacios E, Dallman R, Munoz M, et al. Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38 cases in Lima. Peru Clin Infect Dis. 2009;48(10):1413\u20139.","journal-title":"Peru Clin Infect Dis"},{"issue":"4","key":"5416_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5588\/ijtld.10.0140","volume":"15","author":"P Tabarsi","year":"2011","unstructured":"Tabarsi P, Moradi A, Baghaei P, et al. Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy. Int J Tuberc Lung Dis. 2011;15(4):547\u201350.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"5416_CR21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1590\/S0037-86822011000500020","volume":"44","author":"HB Oliveira","year":"2011","unstructured":"Oliveira HB, Mateus SH. Characterization of multidrug-resistant tuberculosis during pregnancy in Campinas, state of Sao Paulo, Brazil, from 1995 to 2007. Rev Soc Bras Med Trop. 2011;44(5):627\u201330.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"14","key":"5416_CR22","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1097\/00002030-200109280-00016","volume":"15","author":"M Khan","year":"2001","unstructured":"Khan M, Pillay T, Moodley JM, Connolly CA. Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa. AIDS. 2001;15(14):1857\u201363.","journal-title":"AIDS"},{"issue":"5","key":"5416_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.7196\/SAMJ.2019.v109i5.13789","volume":"109","author":"J Zenhausern","year":"2019","unstructured":"Zenhausern J, Bekker A, Wates MA, Schaaf HS, Dramowski A. Tuberculosis transmission in a hospitalised neonate: need for optimised tuberculosis screening of pregnant and postpartum women. S Afr Med J. 2019;109(5):310\u20133.","journal-title":"S Afr Med J"},{"issue":"6","key":"5416_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/cid\/civ991","volume":"62","author":"A Gupta","year":"2016","unstructured":"Gupta A, Mathad JS, Abdel-Rahman SM, et al. Toward earlier inclusion of pregnant and postpartum women in tuberculosis drug trials: consensus statements from an international expert panel. Clin Infect Dis. 2016;62(6):761\u20139.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"5416_CR25","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.5588\/ijtld.12.0068","volume":"17","author":"J Uwimana","year":"2013","unstructured":"Uwimana J, Jackson D. Integration of tuberculosis and prevention of mother-to-child transmission of HIV programmes in South Africa. Int J Tuberc Lung Dis. 2013;17(10):1285\u201390.","journal-title":"Int J Tuberc Lung Dis."},{"issue":"2","key":"5416_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0020-7292(94)90064-7","volume":"44","author":"N Jana","year":"1994","unstructured":"Jana N, Vasishta K, Jindal SK, Khunnu B, Ghosh K. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis. Int J Gynaecol Obstet. 1994;44(2):119\u201324.","journal-title":"Int J Gynaecol Obstet"},{"key":"5416_CR27","first-page":"2009","volume-title":"Treatment of tuberculosis: guidelines","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. Treatment of tuberculosis: guidelines, vol. 420. 4th ed. Geneva: WHO; 2009. p. 2009.","edition":"4"},{"issue":"11","key":"5416_CR28","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1086\/430066","volume":"40","author":"PC Drobac","year":"2005","unstructured":"Drobac PC, del Castillo H, Sweetland A, et al. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents. Clin Infect Dis. 2005;40(11):1689\u201392.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"5416_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1473-3099(04)00939-9","volume":"4","author":"T Pillay","year":"2004","unstructured":"Pillay T, Khan M, Moodley J, Adhikari M, Coovadia H. Perinatal tuberculosis and HIV-1: considerations for resource-limited settings. Lancet Infect Dis. 2004;4(3):155\u201365.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"5416_CR30","first-page":"983","volume":"91","author":"T Pillay","year":"2001","unstructured":"Pillay T, Khan M, Moodley J, et al. The increasing burden of tuberculosis in pregnant women, newborns and infants under 6 months of age in Durban, KwaZulu-Natal. S Afr Med J. 2001;91(11):983\u20137.","journal-title":"S Afr Med J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05416-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T23:08:48Z","timestamp":1631920128000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05416-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5416"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05416-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"assertion":[{"value":"20 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All study participants provided voluntary, written informed consent prior to study. Participation. The Harvard School of Public Health and Peru\u2019s National Institute of Health provided Institutional Review Board approval.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"686"}}